CSL Behring is a global biotechnology leader, driven by our promise to save lives and meet patients’ needs. Every day we work as if someone’s life depends on it, because it does.
Innovation is in our DNA
Our global research and development organization is driven by an experienced team of 1,700 scientists who use the latest technologies to develop innovative therapies that reach patients in more than 60 countries. Over the last five years, we have invested more than $2.9 billion in research and development (R&D).
Ask any CSL employee why they work here and the first answer is generally the same — “I come to work every day like someone’s life depends on it … because it does.”
Innovation is in our DNA
Our global research and development organization is driven by an experienced team of 1,700 scientists who use the latest technologies to develop innovative therapies that reach patients in more than 60 countries. Over the last five years, we have invested more than $2.9 billion in research and development (R&D).
Broadest range of products in the industry
We offer the broadest range of quality products in our industry for treating coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease, and neurological disorders. CSL Behring products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic disease of the newborn.
Breakthrough medicines and innovative technologies
One of the promising compounds in our R&D pipeline is CSL112. Also known as Apolipoprotein A-1 human, CSL112 is being developed to reduce the risk of early recurrent cardiovascular events that occur in the weeks and months following a heart attack. CSL112 enhances the body’s primary mechanism of removing excess cholesterol from atherosclerotic plaques that can contribute to its rupture.
We are also developing ex vivo hematopoietic stem cell gene therapy for the treatment of sickle cell disease and β-thalassemia, which complements our current product portfolio and deep expertise in hematology. Our unique platform technologies are designed to address some of the major challenges currently associated with the commercialization of stem cell therapy, including the ability to manufacture consistent, high-quality products and improve engraftment, efficacy, and tolerability.
Global recognition
We are proud to be recognized as a top employer – 2018 Forbes Top 50 Employers in the world and Thomson Reuters Top 100 Diversity & Inclusion Index. Our work has been recognized by patient groups such as the National Organization for Rare Disorders (Industry Innovation Award), European Organization for Rare Diseases (EURORDIS Award) and the National Hemophilia Foundation (Corporate Leadership Award). Our sites in several countries have received a “Best Places to Work” Award, in addition to the above-mentioned Forbes and Thomson Reuters recognition.
Our culture and workplace
Ask any CSL employee why they work here and the first answer is generally the same — “I come to work every day like someone’s life depends on it … because it does.”
It is this patient focus and passion for our work that attracts people to CSL. If you want to contribute to a company that puts patients at the center of how we operate and innovate, the decisions and investments we make and the impact we have on the health of our communities, CSL Behring is that organization.
Cornerstone of innovation
Collaboration coupled with a dedication to research and science is the cornerstone of innovation. We work together, listening to one another, considering different perspectives and always striving to find a better medicine, process, tool or technology in our quest for continuous improvement. We specifically look for individuals who possess exceptional skills and inspire others through their commitment to deliver on commitments. We want individuals who can envision the possibilities, listen, share, debate and ultimately unite around decisions that will benefit our patients.
Stretching and developing employees
When describing what makes CSL Behring a special place to work and grow their careers, employees often talk about how we’ve maintained our entrepreneurial spirit, but with sustainable growth and development opportunities. We invest in learning and career development because we believe all employees should have the opportunity to fulfill their individual career aspirations and potential. Our leaders are particularly good at finding opportunities to stretch and develop employees. They want people to try new things, whether that’s a project on their current team or an opportunity to join a different team, at times in a different country. Our leaders don’t hoard good talent. Instead, they work to find where an employee can have the greatest impact and growth. At CSL Behring, employees are proud to belong to a community of committed individuals who work hard every day to make a difference for people around the world with rare and serious diseases.
Our Values
Patient Focus / We deliver on our promise to patients.
Innovation / We turn innovative thinking into solutions.
Integrity / We walk the talk.
Collaboration / We are stronger together.
Superior Performance / We take pride in our results.
